dbo:abstract
|
- Crisnatol (BW-A770U) is an experimental anticancer agent. A Phase I clinical trial was published in 1999. (en)
|
dbo:casNumber
| |
dbo:fdaUniiCode
| |
dbo:pubchem
| |
dbo:thumbnail
| |
dbo:wikiPageID
| |
dbo:wikiPageLength
|
- 2037 (xsd:nonNegativeInteger)
|
dbo:wikiPageRevisionID
| |
dbo:wikiPageWikiLink
| |
dbp:atcPrefix
| |
dbp:c
| |
dbp:casNumber
| |
dbp:chemspiderid
| |
dbp:h
| |
dbp:iupacName
| |
dbp:n
| |
dbp:o
| |
dbp:pubchem
| |
dbp:smiles
|
- CCNCc1cc2c3ccccc3ccc2c4c1cccc4 (en)
|
dbp:stdinchi
|
- InChI=1S/C23H23NO2/c1-2324-13-17-12-22-18-7-3-2-6-1610-11-2120-9-5-4-8-1920/h2-12,24-26H,13-15H2,1H3 (en)
|
dbp:stdinchikey
|
- SBRXTSOCZITGQG-UHFFFAOYSA-N (en)
|
dbp:unii
| |
dbp:wikiPageUsesTemplate
| |
dcterms:subject
| |
gold:hypernym
| |
rdf:type
| |
rdfs:comment
|
- Crisnatol (BW-A770U) is an experimental anticancer agent. A Phase I clinical trial was published in 1999. (en)
|
rdfs:label
| |
owl:sameAs
| |
prov:wasDerivedFrom
| |
foaf:depiction
| |
foaf:isPrimaryTopicOf
| |
is dbo:wikiPageRedirects
of | |
is dbo:wikiPageWikiLink
of | |
is foaf:primaryTopic
of | |